APO-Remifentanil remifentanil (as hydrochloride) 5 mg powder for injection vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

remifentanil hydrochloride, Quantity: 5.485 mg

Boleh didapati daripada:

Arrotex Pharmaceuticals Pty Ltd

INN (Nama Antarabangsa):

Remifentanil hydrochloride

Borang farmaseutikal:

Injection, powder for

Komposisi:

Excipient Ingredients: glycine; hydrochloric acid

Laluan pentadbiran:

Intravenous Infusion

Unit dalam pakej:

5 x 5 mg

Jenis preskripsi:

(S8) Controlled Drug

Tanda-tanda terapeutik:

Remifentanil is indicated:,- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures, including cardiac surgery, in adults;,- as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical, but not cardiac procedures, in children aged 1?12 years;,- for continuation as an analgesic into the immediate post-operative period under the close supervision of medically-qualified persons trained in the use of anaesthetic agents, during transition to longer-acting analgesia following adult cardiac surgery ? when endotracheal intubation and controlled ventilation are anticipated;,- for provision of analgesia and sedation in mechanically-ventilated intensive care patients.

Ringkasan produk:

Visual Identification: White to off-white powder; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status kebenaran:

Licence status A

Tarikh kebenaran:

2016-01-06